Christine E. McLaren

8.2k total citations · 3 hit papers
129 papers, 5.9k citations indexed

About

Christine E. McLaren is a scholar working on Hematology, Genetics and Nutrition and Dietetics. According to data from OpenAlex, Christine E. McLaren has authored 129 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 53 papers in Genetics and 28 papers in Nutrition and Dietetics. Recurrent topics in Christine E. McLaren's work include Iron Metabolism and Disorders (60 papers), Hemoglobinopathies and Related Disorders (53 papers) and Trace Elements in Health (23 papers). Christine E. McLaren is often cited by papers focused on Iron Metabolism and Disorders (60 papers), Hemoglobinopathies and Related Disorders (53 papers) and Trace Elements in Health (23 papers). Christine E. McLaren collaborates with scholars based in United States, Canada and Australia. Christine E. McLaren's co-authors include Paul C. Adams, Victor R. Gordeuk, Gordon D. McLaren, Frank L. Meyskens, Wen‐Pin Chen, James C. Barton, Ronald T. Acton, John H. Eckfeldt, Mark Speechley and Philip M. Carpenter and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Christine E. McLaren

124 papers receiving 5.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population

2005 547 citations Paul C. Adams, David M. Reboussin et al. New England Journal of Medicine profile →
Iron-Overload–Related Disease inHFEHereditary Hemochromatosis

2008 494 citations Katrina J. Allen, Lyle C. Gurrin et al. New England Journal of Medicine profile →
Haemochromatosis

2018 251 citations Paul C. Adams, Christine E. McLaren et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine E. McLaren United States	40	2.6k	2.3k	1.6k	970	482	129	5.9k
Heinz Zoller Austria	44	2.6k 1.0×	1.7k 0.7×	1.7k 1.1×	563 0.6×	485 1.0×	188	5.9k
Antonio Piga Italy	44	6.1k 2.3×	6.7k 3.0×	1.2k 0.8×	626 0.6×	271 0.6×	195	8.8k
Eliezer A. Rachmilewitz Israel	44	4.6k 1.7×	5.1k 2.3×	828 0.5×	1.4k 1.4×	231 0.5×	169	7.7k
Iain C. Macdougall United Kingdom	49	6.6k 2.5×	3.1k 1.4×	704 0.4×	1.7k 1.7×	715 1.5×	187	12.0k
Nancy F. Olivieri Canada	51	6.4k 2.4×	7.3k 3.2×	1.1k 0.7×	1.0k 1.0×	324 0.7×	169	9.4k
John K. Olynyk Australia	54	4.5k 1.7×	3.6k 1.6×	2.7k 1.7×	1.0k 1.1×	744 1.5×	269	9.9k
Christian Datz Austria	43	1.4k 0.5×	909 0.4×	1.1k 0.7×	877 0.9×	544 1.1×	176	6.3k
Maurizio Margaglione Italy	50	3.9k 1.5×	1.3k 0.6×	344 0.2×	1.2k 1.3×	302 0.6×	271	9.1k
Vicente Vicente Spain	53	4.5k 1.7×	1.2k 0.5×	352 0.2×	2.1k 2.2×	851 1.8×	497	11.4k
Jack F.M. Wetzels Netherlands	66	1.5k 0.6×	1.3k 0.6×	601 0.4×	3.4k 3.5×	704 1.5×	394	14.3k

Countries citing papers authored by Christine E. McLaren

Since Specialization

Citations

This map shows the geographic impact of Christine E. McLaren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine E. McLaren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine E. McLaren more than expected).

Fields of papers citing papers by Christine E. McLaren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine E. McLaren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine E. McLaren. The network helps show where Christine E. McLaren may publish in the future.

Co-authorship network of co-authors of Christine E. McLaren

This figure shows the co-authorship network connecting the top 25 collaborators of Christine E. McLaren. A scholar is included among the top collaborators of Christine E. McLaren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine E. McLaren. Christine E. McLaren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zell, Jason A., Thomas H. Taylor, Gregory Albers, et al.. (2023). Phase IIa Clinical Biomarker Trial of Dietary Arginine Restriction and Aspirin in Colorectal Cancer Patients. Cancers. 15(7). 2103–2103. 4 indexed citations

Zell, Jason A., Christine E. McLaren, Timothy R. Morgan, et al.. (2019). A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index. Cancer Prevention Research. 13(2). 203–212. 23 indexed citations

Barton, James C., Wen‐Pin Chen, Mary J. Emond, et al.. (2016). GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes. Blood Cells Molecules and Diseases. 63. 15–20. 12 indexed citations

Linden, Kenneth G., Sancy A. Leachman, Jonathan S. Zager, et al.. (2014). A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology. Cancer Prevention Research. 7(5). 496–504. 20 indexed citations

Zaloumis, Sophie, Katrina J. Allen, Nadine A. Bertalli, et al.. (2014). Natural history of HFE simple heterozygosity for C282Y and H63D: A prospective 12‐year study. Journal of Gastroenterology and Hepatology. 30(4). 719–725. 23 indexed citations

Chen, Jonathan H., et al.. (2013). Correlation of endogenous hormonal levels, fibroglandular tissue volume and percent density measured using 3D MRI during one menstrual cycle. Annals of Oncology. 24(9). 2329–2335. 14 indexed citations

Carroll, Robert E., Richard V. Benya, D. Kim Turgeon, et al.. (2011). Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia. Cancer Prevention Research. 4(3). 354–364. 403 indexed citations

Mainous, Arch G., Vanessa A. Díaz, Charles J. Everett, et al.. (2011). IRon overload screeNing tool (IRON): Development of a tool to guide screening in primary care. American Journal of Hematology. 86(9). 733–737. 7 indexed citations

Chorney, Jill, Carrie L. Torrey, Ronald L. Blount, et al.. (2009). Healthcare Provider and Parent Behavior and Children’s Coping and Distress at Anesthesia Induction. Anesthesiology. 111(6). 1290–1296. 43 indexed citations

10.

Osborne, Nicholas J., Lyle C. Gurrin, Katrina J. Allen, et al.. (2009). HFE C282Y homozygotes are at increased risk of breast and colorectal cancer†. Hepatology. 51(4). 1311–1318. 106 indexed citations

11.

McLaren, Christine E., Sharon Fujikawa-Brooks, Wen‐Pin Chen, et al.. (2008). Longitudinal Assessment of Air Conduction Audiograms in a Phase III Clinical Trial of Difluoromethylornithine and Sulindac for Prevention of Sporadic Colorectal Adenomas. Cancer Prevention Research. 1(7). 514–521. 26 indexed citations

12.

Meyskens, Frank L., Christine E. McLaren, Daniel Pelot, et al.. (2008). Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial. Cancer Prevention Research. 1(1). 32–38. 392 indexed citations

13.

Allen, Katrina J., Lyle C. Gurrin, Clare C. Constantine, et al.. (2008). Iron-Overload–Related Disease inHFEHereditary Hemochromatosis. New England Journal of Medicine. 358(3). 221–230. 494 indexed citations breakdown →

14.

Gurrin, Lyle C., Nicholas J. Osborne, Clare C. Constantine, et al.. (2008). The Natural History of Serum Iron Indices for HFE C282Y Homozygosity Associated With Hereditary Hemochromatosis. Gastroenterology. 135(6). 1945–1952. 63 indexed citations

15.

Barton, James C., Ronald T. Acton, Catherine Leiendecker‐Foster, et al.. (2007). HFE C282Y Homozygotes Aged 25–29 Years at HEIRS Study Initial Screening. Genetic Testing. 11(3). 269–275. 6 indexed citations

16.

Barton, James C., Ronald T. Acton, Fitzroy W. Dawkins, et al.. (2005). Initial Screening Transferrin Saturation Values, Serum Ferritin Concentrations, and HFE Genotypes in Whites and Blacks in the Hemochromatosis and Iron Overload Screening Study. Genetic Testing. 9(3). 231–241. 59 indexed citations

17.

Lacerda, Lúcia, Fernando A. Arosa, Rosa Lacerda, et al.. (1999). T Cell Numbers Relate to Bone Involvement in Gaucher Disease. Blood Cells Molecules and Diseases. 25(2). 130–138. 40 indexed citations

18.

Moyo, Victor, Innocent T. Gangaidzo, Victor R. Gordeuk, et al.. (1998). African iron overload and hepatocellular carcinoma (HA‐7–0–080). European Journal Of Haematology. 60(1). 28–34. 40 indexed citations

19.

Thuma, Philip E., George F. Mabeza, Godfrey Biemba, et al.. (1998). Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 92(2). 214–218. 62 indexed citations

20.

McCullough, Arthur J., et al.. (1986). Immediate diagnostic criteria for bacterial infection of ascitic fluid. Gastroenterology. 90(5). 1247–1254. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact